Tag: Alexion

January 14, 2020

Alexion Confirms Planned Phase 3 Study of ALS Treatment

Alexion announced that is plans to start a Phase 3 study of ULTOMIRIS (ravulizumab) in amyotrophic lateral sclerosis (ALS).